U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.518del (p.Cys173fs) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 23, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002338787.2

Allele description [Variation Report for NM_000527.5(LDLR):c.518del (p.Cys173fs)]

NM_000527.5(LDLR):c.518del (p.Cys173fs)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.518del (p.Cys173fs)
HGVS:
  • NC_000019.10:g.11105424del
  • NG_009060.1:g.21044del
  • NM_000527.5:c.518delMANE SELECT
  • NM_001195798.2:c.518del
  • NM_001195799.2:c.395del
  • NM_001195800.2:c.314-1968del
  • NM_001195803.2:c.314-1141del
  • NP_000518.1:p.Cys173fs
  • NP_000518.1:p.Cys173fs
  • NP_001182727.1:p.Cys173fs
  • NP_001182728.1:p.Cys132fs
  • LRG_274t1:c.518del
  • LRG_274:g.21044del
  • LRG_274p1:p.Cys173fs
  • NC_000019.9:g.11216100del
  • NC_000019.9:g.11216100delG
  • NM_000527.4:c.518del
  • NM_000527.4:c.518delG
  • c.518delG
  • p.Cys173Serfs*33
Protein change:
C132fs
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000073; dbSNP: rs879254559
NCBI 1000 Genomes Browser:
rs879254559
Molecular consequence:
  • NM_000527.5:c.518del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195798.2:c.518del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195799.2:c.395del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195800.2:c.314-1968del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195803.2:c.314-1141del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002644165Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Feb 23, 2018)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants.

Huijgen R, Kindt I, Defesche JC, Kastelein JJ.

Eur Heart J. 2012 Sep;33(18):2325-30. doi: 10.1093/eurheartj/ehs038. Epub 2012 Mar 4.

PubMed [citation]
PMID:
22390909

Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population.

Cenarro A, Jensen HK, Civeira F, Casao E, Ferrando J, González-Bonillo J, Pocoví M, Gregersen N.

Clin Genet. 1996 Apr;49(4):180-5.

PubMed [citation]
PMID:
8828982

Details of each submission

From Ambry Genetics, SCV002644165.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The c.518delG pathogenic mutation, located in coding exon 4 of the LDLR gene, results from a deletion of one nucleotide at nucleotide position 518, causing a translational frameshift with a predicted alternate stop codon (p.C173Sfs*33). This alteration has been reported in individuals with hypercholesterolemia (Cenarro A et al. Clin. Genet., 1996 Apr;49:180-5; Huijgen R et al. Eur. Heart J., 2012 Sep;33:2325-30). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024